1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. CLIMB BIO INC.
Climb Bio Inc.
XNAS: CLYM
Download real time
8.91 0.03 (0.34%)
New 52W High in past week
1.8M
XNAS Volume
High volume today

XNAS 01 May, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert


Insider Trading disclosures for Climb Bio Inc

The latest disclosure was made by Stephen Thomas in Climb Bio Inc where a trade of 33,687 Common Stock done at an average price of $7.0 was reported to US exchanges on Feb. 25, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Stephen Thomas Director Sale of securities on an exchange or to another person at price $ 7.00 per share. 25 Feb 2026 33,687 170,970 - 7.0 235,964 Common Stock
Stephen Thomas Director Sale of securities on an exchange or to another person at price $ 7.01 per share. 25 Feb 2026 16,313 154,657 - 7.0 114,289 Common Stock
Stephen Thomas Director Sale of securities on an exchange or to another person at price $ 5.23 per share. 12 Feb 2026 90,000 214,657 - 5.2 470,988 Common Stock
Stephen Thomas Director Sale of securities on an exchange or to another person at price $ 5.81 per share. 12 Feb 2026 10,000 204,657 - 5.8 58,141 Common Stock
Aoife M. Brennan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2026 700,000 700,000 - - Stock Option (Right to Buy)
Cindy Driscoll Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2026 100,000 100,000 - - Stock Option (Right to Buy)
Susan Altschuller Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2026 142,500 142,500 - - Stock Option (Right to Buy)
Perrin Megan Wilson Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Jan 2026 300,000 300,000 - - Stock Option (Right to Buy)
Susan Altschuller Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Oct 2025 600,000 600,000 - - Stock Option (Right to Buy)
Stephen Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Aug 2025 100,375 304,657 - 0 Common Stock
Aoife M. Brennan Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2025 68,750 206,250 - - Restricted Stock Units
Aoife M. Brennan Director, President and CEO Sale of securities on an exchange or to another person at price $ 1.22 per share. 27 Jun 2025 20,618 48,132 - 1.2 25,154 Common Stock
Aoife M. Brennan Director, President and CEO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2025 68,750 68,750 - - Common Stock
Stephen Thomas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2025 25,094 204,282 - - Common Stock
Stephen Thomas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Jun 2025 25,094 0 - - Restricted Stock Units
Emily Pimblett SVP, Finance & CAO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2025 5,000 15,000 - - Restricted Stock Units
Emily Pimblett SVP, Finance & CAO Sale of securities on an exchange or to another person at price $ 1.24 per share. 18 Jun 2025 1,242 18,888 - 1.2 1,540 Common Stock
Emily Pimblett SVP, Finance & CAO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Jun 2025 5,000 20,130 - - Common Stock
Cindy Driscoll Senior Vice President, Finance Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2025 200,000 200,000 - - Stock Option (Right to Buy)
Douglas E. Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 40,000 40,000 - - Stock Option (Right to Buy)
Kimberlee Cobleigh Drapkin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 40,000 40,000 - - Stock Option (Right to Buy)
Alexander G. Cumbo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 40,000 40,000 - - Stock Option (Right to Buy)
Andrew Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 40,000 40,000 - - Stock Option (Right to Buy)
Judith A. Dunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 40,000 40,000 - - Stock Option (Right to Buy)
Stephen Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Jun 2025 40,000 40,000 - - Stock Option (Right to Buy)
Douglas E. Williams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Mar 2025 78,873 78,873 - - Stock Option (Right to Buy)
Kimberlee Cobleigh Drapkin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2025 80,000 80,000 - - Stock Option (Right to Buy)
Alexander G. Cumbo Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2025 80,000 80,000 - - Stock Option (Right to Buy)
Stephen Thomas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Mar 2025 25,093 179,188 - - Common Stock
Stephen Thomas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 27 Mar 2025 25,093 25,094 - - Restricted Stock Units
Emily Pimblett SVP, Finance & CAO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2025 5,000 16,329 - - Common Stock
Emily Pimblett SVP, Finance & CAO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 18 Mar 2025 5,000 20,000 - - Restricted Stock Units
Emily Pimblett SVP, Finance & CAO Sale of securities on an exchange or to another person at price $ 1.31 per share. 18 Mar 2025 1,199 15,130 - 1.3 1,571 Common Stock
Aoife M. Brennan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2025 1,150,000 1,150,000 - - Stock Option (Right to Buy)
Brett Kaplan Chief Operating Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2025 500,000 500,000 - - Stock Option (Right to Buy)
Emily Pimblett SVP, Finance and CAO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jan 2025 100,000 100,000 - - Stock Option (Right to Buy)
Stephen Thomas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2025 50,188 154,095 - - Common Stock
Stephen Thomas Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jan 2025 50,188 50,187 - - Restricted Stock Units
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Dec 2024 1,235 11,329 - 2.0 2,495 Common Stock
Pimblett Emily CHIEF ACCOUNTING OFFICER 18 Dec 2024 5,000 25,000 - - Restricted Stock Units
Pimblett Emily CHIEF ACCOUNTING OFFICER 18 Dec 2024 5,000 12,564 - - Common Stock
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Sep 2024 5,000 30,000 - - Restricted Stock Units
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Sep 2024 9 7,564 - 8.1 73 Common Stock
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Sep 2024 1,182 7,573 - 8.2 9,669 Common Stock
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Sep 2024 5,000 8,755 - - Common Stock
Brett Kaplan Chief Operating Officer 26 Aug 2024 77,500 77,500 - - Restricted Stock Units
Brett Kaplan Chief Operating Officer 26 Aug 2024 465,000 465,000 - - Stock Option (Right to Buy)
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 7.24 per share. 19 Jul 2024 50,000 100,322 - 7.2 362,000 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 7.98 per share. 19 Jul 2024 30,000 31,317 - 8.0 239,400 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 8.07 per share. 19 Jul 2024 39,005 61,317 - 8.1 314,770 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 7.09 per share. 19 Jul 2024 10,201 150,322 - 7.1 72,325 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 6.91 per share. 17 Jul 2024 3,207 199,099 - 6.9 22,160 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 6.93 per share. 17 Jul 2024 38,576 160,523 - 6.9 267,332 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 7.13 per share. 16 Jul 2024 50,000 202,306 - 7.1 356,500 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 7.01 per share. 12 Jul 2024 42,377 252,306 - 7.0 297,063 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 7.07 per share. 12 Jul 2024 50,000 294,683 - 7.1 353,500 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 7.11 per share. 09 Jul 2024 50,000 344,683 - 7.1 355,500 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 6.83 per share. 09 Jul 2024 50,000 394,683 - 6.8 341,500 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 6.66 per share. 09 Jul 2024 5,931 444,683 - 6.7 39,500 Common Stock
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 7.06 per share. 05 Jul 2024 12,342 450,614 - 7.1 87,135 Common Stock
Valerie Morisset EVP, R&D AND CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2024 7,649 512,956 - 0.0 2 Common Stock
Valerie Morisset EVP, R&D AND CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 01 Jul 2024 7,649 10,198 - - Stock Option (Right to Buy)
Valerie Morisset EVP, R&D AND CSO Sale of securities on an exchange or to another person at price $ 6.76 per share. 01 Jul 2024 50,000 462,956 - 6.8 338,000 Common Stock
Aoife M. Brennan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2024 550,000 550,000 - - Stock Option (Right to Buy)
Aoife M. Brennan Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2024 275,000 275,000 - - Restricted Stock Units
Stephen Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2024 100,375 100,375 - - Restricted Stock Units
Stephen Thomas Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jun 2024 103,907 103,907 - - Common Stock
Liam Ratcliffe Director 26 Jun 2024 10,000 10,000 - - Stock Option (Right To Buy)
Andrew Levin Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 10,000 10,000 - - Stock Option (Right To Buy)
Judith A. Dunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jun 2024 10,000 10,000 - - Stock Option (Right To Buy)
Adam Rosenberg Director 26 Jun 2024 10,000 10,000 - - Stock Option (Right To Buy)
Simon Tate Director 26 Jun 2024 10,000 10,000 - - Stock Option (Right To Buy)
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Jun 2024 5,000 5,000 - - Common Stock
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Jun 2024 1,245 3,755 - 7.2 8,982 Common Stock
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Jun 2024 5,000 35,000 - - Restricted Stock Units
Valerie Morisset EVP, R&D AND CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2024 17,847 505,307 - 0.0 4 Common Stock
Valerie Morisset EVP, R&D AND CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 05 Apr 2024 17,847 28,046 - - Stock Option (Right to Buy)
Emily Pimblett CHIEF ACCOUNTING OFFICER 18 Mar 2024 40,000 40,000 - - Restricted Stock Units
Valerie Morisset EVP, R&D AND CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2023 15,297 487,460 - 0.0 3 Common Stock
Valerie Morisset EVP, R&D AND CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2023 5,431 0 - - Stock Option (Right to Buy)
Valerie Morisset EVP, R&D AND CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2023 15,297 45,893 - - Stock Option (Right to Buy)
Valerie Morisset EVP, R&D AND CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Sep 2023 5,431 472,163 - 0.0 11 Common Stock
Liam Ratcliffe Director 18 May 2023 10,000 10,000 - - Stock Option (Right To Buy)
Andrew Levin Director, Executive Chairman Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 10,000 10,000 - - Stock Option (Right To Buy)
Judith A. Dunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 May 2023 10,000 10,000 - - Stock Option (Right To Buy)
Adam Rosenberg Director 18 May 2023 10,000 10,000 - - Stock Option (Right To Buy)
Simon Tate Director 18 May 2023 10,000 10,000 - - Stock Option (Right To Buy)
Valerie Morisset EVP, R&D and CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2023 255,219 405,541 - 0.0 510 Common Stock
Valerie Morisset EVP, R&D and CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2023 61,191 61,190 - - Stock Option (Right to Buy)
Valerie Morisset EVP, R&D and CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2023 255,219 5,431 - - Stock Option (Right to Buy)
Valerie Morisset EVP, R&D and CSO Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 10 Mar 2023 61,191 466,732 - 0.0 12 Common Stock
James B. Bucher EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2022 95,000 95,000 - - Stock Option (Right to Buy)
Robert W. Azelby Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2022 500,000 500,000 - - Stock Option (Right to Buy)
Erin M. Lavelle COO & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2022 170,000 170,000 - - Stock Option (Right to Buy)
Valerie Morisset EVP, R&D and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Oct 2022 170,000 170,000 - - Stock Option (Right to Buy)
Leone D. Patterson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 10,000 10,000 - - Stock Option (Right To Buy)
Liam Ratcliffe Director 19 May 2022 10,000 10,000 - - Stock Option (Right To Buy)
Andrew Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 10,000 10,000 - - Stock Option (Right to Buy)
Judith A. Dunn Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2022 10,000 10,000 - - Stock Option (Right To Buy)
Adam Rosenberg Director 19 May 2022 10,000 10,000 - - Stock Option (Right To Buy)
Simon Tate Director 19 May 2022 10,000 10,000 - - Stock Option (Right To Buy)
James B. Bucher EVP and General Counsel Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2022 95,000 95,000 - - Stock Option (Right to Buy)
Robert W. Azelby Director, President & CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2022 500,000 500,000 - - Stock Option (Right to Buy)
Erin M. Lavelle COO & CFO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2022 170,000 170,000 - - Stock Option (Right to Buy)
Valerie Morisset EVP, R&D and CSO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2022 170,000 170,000 - - Stock Option (Right to Buy)
Liam Ratcliffe Director 09 Aug 2021 20,000 20,000 - - Stock Option (Right to Buy)
Andrew Levin Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 09 Aug 2021 20,000 20,000 - - Stock Option (Right to Buy)
Adam Rosenberg Director 09 Aug 2021 20,000 20,000 - - Stock Option (Right to Buy)
Simon Tate Director 09 Aug 2021 20,000 20,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters